DexCom
DXCM
966 hedge funds and large institutions have $25.9B invested in DexCom in 2026 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 390 increasing their positions, 344 reducing their positions, and 100 closing their positions.
25% more first-time investments, than exits
New positions opened: 125 | Existing positions closed: 100
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
13% more repeat investments, than reductions
Existing positions increased: 390 | Existing positions reduced: 344
11% more capital invested
Capital invested by funds: $23.4B → $25.9B (+$2.52B)
3.07% more ownership
Funds ownership: 96.63% → 99.7% (+3.1%)
1% more funds holding
Funds holding: 960 → 966 (+6)
10% less call options, than puts
Call options by funds: $315M | Put options by funds: $351M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$288M |
| 2 |
CHP
Castle Hook Partners
New York
|
+$204M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$114M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$108M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$108M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$178M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$86.9M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$86.2M |
| 4 |
SG Americas Securities
New York
|
-$83M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$82M |
DXCM Hedge Fund Activity: Q2 2026 in Review
966 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2026, worth a combined $25.9B — up 11% from $23.4B a quarter earlier.
Buyers outnumbered sellers: 125 funds opened new DXCM positions and 100 closed out — a net gain of 25 holders — while 390 added to existing stakes and 344 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $288M. The largest seller was JP Morgan Chase, cutting an estimated $178M.
- 966 institutional investors held DexCom (DXCM) as of Q2 2026, up from 960 in Q1 2026.
- Funds reported $25.9B of DexCom stock for Q2 2026, up 11% quarter-over-quarter.
- 125 funds opened new DexCom positions in Q2 2026 and 100 closed out, a net change of +25 holders.
- The largest DexCom buyer in Q2 2026 was Arrowstreet Capital, an estimated $288M added.
- The largest DexCom seller in Q2 2026 was JP Morgan Chase, an estimated $178M sold.
Based on aggregated 13F filings for Q2 2026.